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Summary
Lethal congenital contracture syndrome (LCCS) is an
autosomal recessive disease leading to death before the
32d gestational week. It is characterized by the fetal
akinesia phenotype, with highly focused degeneration of
motoneurons in the spinal cord as the main neuropath-
ological finding. We report here the assignment of the
LCCS locus to a defined region of chromosome 9q34,
between markers D9S1825 and D9S1830. The initial
genome scan was performed with the DNA samples of
only five affected individuals from two unrelated LCCS
families. The conventional linkage analysis performed
with 20 affected individuals and their families was fo-
cused on those chromosomal regions in which the af-
fected siblings were identical by descent in the initial
scan. One core haplotype of 3 cMwas observed in LCCS
alleles, supporting the assumption of one major muta-
tion underlying LCCS, and linkage disequilibrium anal-
ysis restricted the critical chromosomal region to !100
kb in the vicinity of marker D9S61. Two genes, NGAL
(neutrophil gelatinase–associated lipocalin andNOTCH
1, were excluded as causative genes for LCCS
Introduction
Lethal congenital contracture syndrome ( LCCS) is an
autosomal recessive syndrome (MIM 253310) (Herva et
al. 1985) leading to prenatal death of the affected fetus
before the 32d week of gestation. The LCCS fetuses
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present with a typical fetal akinesia phenotype withmul-
tiple contractures of joints. The degeneration of descend-
ing tracts and anterior-horn motoneurons of the spinal
cord is the main histopathological finding (Herva et al.
1988; Vuopala and Herva 1994). The etiology and path-
ological mechanism of LCCS are still unknown.
To date, a total of 43 LCCS cases have been reported,
all from Finland. The disease-gene frequency is ∼.0089
in Finland but is higher, ∼.016, in the northeastern part
of Finland, showing enrichment of the disease in the
genetically isolated subpopulation of the later-settled
area of this country (Vuopala and Herva 1994). In such
a setting the disease can be assumed to be caused by a
single major mutation, and linkage disequilibrium
should be detectable by use of markers flanking the dis-
ease locus (Ha¨stbacka et al. 1992). Consequently, the
search for a shared chromosomal segment is the method
of choice in the search for the disease locus, necessitating
initial genotyping of only a small number of affected
individuals (Houwen et al. 1994; Nikali et al. 1995).
Here we report the assignment of the LCCS locus by
means of a genomewide scan based on the initial ge-
notyping of five affected individuals from two families.
Further linkage analyses in the complete study material
of 10 families revealed evidence for linkage on 9q33-
34. Two genes—NOTCH1 (Larsson et al. 1994) and
NGAL (Chan et al. 1994)—that previously had been
assigned to this chromosomal region were excluded as
causative genes.
Subjects and Methods
Subjects
The 10 LCCS pedigrees used in this study are shown
in figure 1. The mean gestational age of the fetuses was
27 wk. Growth retardation occurred during the second
half of the gestation period, and the hydrops observed
in early pregnancy disappeared during development. The
typical LCCS phenotype included low-set and posteri-
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Figure 1 LCCS pedigrees. Blackened symbols denote affected individuals; asterisks denote affected individuals whose DNA samples were
analyzed in the initial genome scan, and triangles denote individuals whose DNA was isolated from paraffin-embedded samples. DNA samples
of all the family members from these 10 families were used for genotyping and in linkage analyses.
orly angulated ears, pterygia at the elbows, hypoplastic
jaw, and sticklike extremities with multiple joint con-
tractures. The autopsy showed pulmonary hypoplasia ,
skeletal muscle atrophy, and a marked reduction of mo-
tor neurons in the ventral part of the spinal cord. The
rest of the CNS was intact. The spinal cord from at least
one affected sibling in each family was available for neu-
ropathological examination (Vuopala and Herva 1994;
Vuopala et al. 1994). All samples were collected in ac-
cordance with the Helsinki Declaration.
DNA-Marker Analysis
Total DNA was extracted from the leukocytes of pe-
ripheral blood samples from the parents and their
healthy offspring and from tissue samples or cultured
cells of the LCCS fetuses, in accordance with standard
procedures. Samples were available from 13 LCCS fe-
tuses: fibroblasts from 7, liver tissue from 1, and pla-
cental tissue from 5. The paraffin-embedded tissue sam-
ples were available from seven affected fetuses. The age
of the available paraffin-embedded tissues was 7–12
years. All the paraffin-embedded tissues were stored at
room temperature. DNA extraction from paraffin-em-
bedded tissues from four patients was kindly performed
by Dr. K. Zerres. The other three samples were depar-
affinized, and the DNA was released from cells by the
rapid-lysis method (Isola et al. 1994). These samples
increased significantly the informativeness of our family
material.
The genomewide scan for linkage was performed by
use of polymorphic tetra-, tri-, or dinucleotide DNA
markers selected from either the Ge´ne´thon primers col-
lection or the Cooperative Human linkage Center
(CHLC) (Sheffield et al. 1995). The primers for the
CHLC markers either were purchased from the Nordic
Human Genome Initiative or were synthesized in our
laboratory by means of a 394 DNA/RNA Synthesizer
(Applied Biosystem). The polymorphic dinucleotide re-
peats were amplified by PCR, and the products were
separated either by PAGE, as described elsewhere (Vuo-
pala et al. 1995), or on an automated laser-fluorescence
DNA sequencer (ALF; Pharmacia); and the tetra- and
trinucleotide markers were fluorescence 5′ end–labeled
(with either FITC or cyp5), and the amplified PCR prod-
ucts were separated on an automated laser-fluorescence
DNA sequencer (ALF; Pharmacia).
Linkage Analysis
To confirm that our study material was sufficient to
provide conclusive evidence for linkage, the MSIM op-
tion of the SLINK computer program of the LINKAGE
package was used (Ott 1989; Weeks et al. 1990). The
parameters applied in linkage analyses were an auto-
somal recessive trait with .0089 gene frequency and,
because of the lethality of the disease, complete pene-
trance. Five hundred replicates of the studied pedigrees
revealed an average expected LOD score of 4.3, with an
SD of 1.3 and a maximum LOD score of 6.5. Two-point
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linkage analyses were performed by means of the
MLINK option of the LINKAGE package, and multi-
point analyses were performed by means of the LINK-
MAP option, version FASTLINK 2.2 (Lathrop and La-
louel 1984; Lathrop et al. 1984, 1986). The order and
distances between the analyzed markers were based on
either published marker maps (the Genetic Location Da-
tabase; Ge´ne´thon) or FISH analysis of metaphase chro-
mosomes. The HOMOG program was used to test for
locus heterogeneity (Ott 1986).
Linkage-Disequilibrium Analyses
The tests for allelic association were performed by
means of the TDT LIKE and HRRLAMB programs (Ni-
kali et al. 1995; Terwilliger 1995). The haplotype rel-
ative rate (HRR) analysis takes into account also the
allele information from homozygous parents, which is
excluded in the transmission/disequilibrium test (TDT)
analysis. Pexcess is calculated by means of the formula
, in which Paffected isP  (P  P )/(1 P )excess affected normal normal
the allele frequency, among the disease chromosomes, of
a marker locus descending from the ancestral haplotype
and Pnormal is the frequency of the same allele among the
nondisease chromosomes (Luria and Delbru¨ck 1943;
Ha¨stbacka et al. 1992; Hellsten et al. 1993). The Luria-
Delbru¨ck formula was used to estimate the genetic dis-
tance between the markers giving significant Pexcess values
and the hypothetical LCCS gene. Multipoint analysis
adapting linkage disequilibrium was performed with the
DISMULT program (Terwilliger 1995). In this method
the distances between the analyzed markers are fixed,
and the program maximizes the likelihood at a given
map position, as a function of the proportion of disease
alleles (a values) and the number of generations (n val-
ues) since the disease allele has been introduced into the
population.
Visual Mapping by FISH
The P1-derived artificial clones (PACs) were isolated
from a genomic PAC library kindly provided by P. J. de
Jong (Ioannou et al. 1994). The bacterial artificial clones
(BACs) were obtained from Genome Systems. The
probes were labeled by nick translation with either bi-
otin-11-dUTP (Sigma) or digoxigenin-11-dUTP (Boeh-
ringer Mannheim). The size range of the labeled probe
fragments was 300–800 bp, as estimated by agarose-gel
electrophoresis.
For visual mapping, the metaphase spreads from hu-
man peripheral blood lymphocyte cultures were pre-
pared according to standard protocols. Preparation of
extended DNA fibers for use as templates has been de-
scribed in detail elsewhere (Heiskanen et al. 1994, 1996).
Fifty to 150 ng of each of the labeled probes was applied,
per slide, in the presence of a 10–30-fold excess of un-
labeled Cot-1 DNA (Life Technologies). The specific hy-
bridization signals were detected as has been described
elsewhere (Heiskanen et al. 1994). Chromosomal DNA
was counterstained with 0.025 mg of DAPI (4′-6′dia-
mino-2-phenylindole)/ml, and DNA fibers were coun-
terstained with 5 mg of DAPI/ml (Sigma Chemical). The
slides were mounted with antifade solution (Vector Lab-
oratories). Hybridizations were evaluated as described
elsewhere Heiskanen et al. 1996).
DNA Sequencing
According to our FISH results, the NGAL gene resides
in the vicinity of the marker D9S61, which gave the most
significant linkage-disequilibrium values. The PCRprod-
ucts obtained by amplification of the TATA signal region
and of seven exons of the NGAL gene were sequenced
by means of Sanger’s dideoxy-chain termination reaction
(Sanger et al. 1977), as described elsewhere (Syva¨nen et
al. 1989) . The TATA signal region and the exons were
amplified from two patient samples and one control
sample by PCR with intronic primers (European Mo-
lecular Biology Loboratory [accession number
X99133]), in which the reverse primers were bionyty-
lated. The PCR forward primers were used in the se-
quencing reaction. The radiolabeled sequence reaction
products were separated by denaturing polyacrylamide
gels, and the fragments were analyzed by autora-
diography.
Results
Genomewide Scan
The initial genome scan was performed with the
DNAs of five affected individuals from two families with
no known common ancestor throughout six generations,
as verified by church records (the five affected individuals
are denoted by asterisks in fig. 1). The existence of these
two or three affected siblings per family provided uswith
an opportunity to reconstruct, with a relatively high cer-
tainty, the parental haplotypes. Genotyping of 650 poly-
morphic markers with an average density of 5 cM on
autosomes did not reveal, in any of the five affected
individuals, a common haplotype on any chromosomal
segment. However, the haplotypes of the two affected
siblings in family 2 were identical by descent (IBD) for
a total of 18 chromosomal regions, and the three siblings
in family 3 were IBD for 8 regions. Four of the identified
IBD regions were harbored in the same chromosomal
regions, although the affected individuals did not share
identical alleles. The regions extended 12 cM on chro-
mosome 8, 28 cM on chromosome 9, 23 cM on chro-
mosome 10, and 5 cM on chromosome 18. Linkage
analysis using dense marker sets on these four regions
in the complete family material of 10 families with 20
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Table 1
Pairwise LOD Scores between the LCCS Locus and
Markers on 9q, for 10 LCCS Families
LOCUS
LOD SCORE AT v a
.0 .01 .05 .1 .3 .4
GSN 2.30 2.90 2.20 1.50 .80 .23
D9S1850  2.30 .92 .39 .09 .03
D9S1829 1.20 1.30 1.43 1.40 1.10 .61
D9S1881 1.80 1.81 1.64 1.19 .66 .19
D9S1825  .64 1.64 1.75 .36 .10
D9S118 1.70 1.70 1.50 1.20 .40 .10
D9S904 1.70 1.70 1.60 1.40 .50 .20
D9S903 1.30 1.30 1.20 1.00 .40 .10
D9S61 4.70 4.60 4.20 3.60 1.40 .43
D9S752 4.60 4.50 4.00 3.40 1.30 .40
D9S1795 2.20 2.20 2.10 1.80 .70 .20
D9S1831 2.70 2.70 2.40 2.00 .73 .21
D9S1863 3.10 3.00 2.80 2.40 .90 .25
ABL 2.00 2.00 1.90 1.70 .70 .21
D9S179 4.10 4.00 3.60 3.20 1.30 .40
D9S64 3.80 3.70 3.40 3.00 1.20 .40
D9S1830  3.40 3.60 3.20 1.30 .40
a The maximum LOD score for each locus is underlined.
affected individuals revealed evidence for linkage be-
tween the LCCS and the chromosome 9 markers and
excluded the other chromosomal regions.
The results of pairwise linkage analyses obtained with
15 markers on chromosome 9 are shown in table 1. The
maximum pairwise LOD score of 4.7 (recombination
frequency [v] .00) was obtained with the marker D9S61.
The multipoint linkage analysis revealed the maximum
LOD score of 6.5, which peaked between markers
D9S1825 and D9S1830 (fig. 2). No evidence of locus
heterogeneity was observed by HOMOG program.
The obligatory recombinations restricted the LCCS
locus to a 4-cM interval on 9q34. In families 3 and 10,
the recombinations in the affected individuals restricted
the region to a location telomeric to the marker
D9S1825, and one recombination in family 2 in a carrier
sibling positioned the LCCS locus within a region cen-
tromeric to marker D9S1830. With our small family
material, we could not further define the interval for the
LCCS locus.
The mother of family 3 was homozygous for the an-
alyzed markers within the region D9S1825–D9S903. To
exclude the possibility of loss of heterozygosity in this
region, we analyzed the metaphase-chromosome prep-
arations for this mother. The lymphocyte metaphase
spreads were hybridized with the BAC and PAC clones,
with markers D9S61 and D9S904. Respectively, these
probes gave distinct signals on both chromosomes, in-
dicating the presence of this DNA region in both copies
of the mother’s genome.
Restriction of the LCCS Region by Ancient-Haplotype
Analysis
To restrict the critical LCCS region further, extended
haplotypes were built on the basis of alleles detected by
polymorphic markers on 9q34. The 3-cM core haplo-
type 4-4-7-2-1-1-1 (cen-D9S1881-D9S1825-D9S118-
D9S904-D9S903-D9S61-D9S752-tel) was observed in 3
(15%) of 20 disease chromosomes. Furthermore, 19
(95%) of the 20 disease chromosomes carried the same
restricted core haplotype 1-1 with markers D9S61 and
D9S752 separated by 0.5 cM in the genetic maps. The
1-1 haplotype was not observed in any of the 20 non-
disease chromosomes. The ancient recombinations re-
stricting the core haplotype thus would define the critical
LCCS region as spanning ∼0.5 cM between markers
D9S903 and D9S61. The haplotypes of disease chro-
mosomes in individual families are given in table 2.
Fine Mapping of the LCCS Region
With the information obtained with the dense marker
map on 9q34, we used linkage-disequilibrium analysis
to localize the LCCS gene more precisely. The P values
resulting from the TDT test and the l values from the
likelihood-ratio (LRT) tests are shown in table 2. The
most significant P values (!.0002) were observed with
markers D9S61, D9S752, ABL, and D9S179. To per-
form the multiple-loci-association analysis, the DIS-
MULT test was used with fixed values of v (the genetic
distance between the markers). The maximum LOD
score of 6.7 was observed close to marker D9S61, with
an a value of .99 and an n value of 157. These results
are suggestive of a single major and old mutation caus-
ative for LCCS. When this information was adapted to
the Luria-Delbru¨ck formula for markers D9S61 and
D9S752, under the assumption of 1100 generations as
the age of the disease mutation, the critical LCCS region
was estimated to be !100 kb from the marker D9S61
(fig. 3).
Physical Map of the LCCS Locus
PAC and BAC clones were isolated from the cor-
responding libraries by PCR screening with markers
D9S904, D9S61, D9S752, D9S1831, and D9S1863.
These clones and the cosmid clone for the ABL gene
were used as probes in the FISH analysis. Both the
metaphase-chromosomal preparations and the ex-
tended DNA fibers were used as hybridization targets
to determine the order of the clones, as well as to
evaluate the coverage of the physical contig in the
critical region. The order of the markers was estab-
lished to be cen-D9S904-D9S61-D9S752-D9S1831-
D9S1863-ABL-tel. The clones for markers D9S61 and
D9S752 were assigned very close to each other,
whereas the distance between the clones for D9S752
Figure 2 a, Results of multipoint linkage analysis between LCCS and markers on chromosome 9q33-34, positioning the LCCS locus
between markers D9S1825 and D9S1830. The markers and the genetic distances between them are as follows: GSN–7 cM–D9S1850–2.5
cM–D9S1829–0.2 cM–D9S1881–0.1 cM –D9S1825–2 cM–D9S118 –0.5 cM–D9S904–0.1 cM–D9S903–0.1 cM–D9S61–0.1 cM–D9S752 –0.9
cM–D9S1795–0.3 cM–D9S1831–0.9 cM–D9S1863–0.3 cM–ABL–0.1 cM–D9S179–0.1 cM–D9S64–0.1 cM–D9S1830).b, Schematic illustration
of the preliminary physical map is shown over the critical LCCS region. The PAC and BAC clones are shown under the horizontal axis. The
ovals represent polymorphic microsatellites used to isolate the clones. The sizes of the clones and the distances between them are not according
to scale. c, Fiber FISH–based fine-resolution visual mapping of BAC clones for D9S61 (green) and D9S752 (red). d, Fiber FISH–based fine-
resolution visual mapping of BAC clones for D9S752 (green) and of the PAC clone for D9S1831 (yellow). In these analyses, the BAC clones
for D9S61 and D9S752 proved to overlap each other. The physical distance between the BAC clone for D9S752 and the PAC clone for D9S1831
is estimated to be 70 kb.
Table 2
Extended Haplotypes for 11 Markers in the LCCS Locus
Family
D9S1825 D9S118 D9S904 D9S903 D9S61 D9S752 D9S1795 D91831 D9S1863 ABL
HRR l  .58 HRR l  .38 HRR l  0 HRR l  0 HRR l  .91 HRR l  .9 HRR l  0 HRR l  0 HRR l  0 HRR l  .58
TDT P  .0013 TDT P  .0018 TDT P  .05 TDT P  .03 7TDT P  2.0# 10 6TDT P  1.5# 10 TDT P  .1 TDT P  .004 TDT P  .02 TDT P  .0002
1 4 7 2 1 1 1 2 3 2 2
4 2 2 1 1 1 1 3 1 2
2 4 2 2 1 1 1 3 4 1 2
4 7 2 1 1 1 1 2 2 2
3 3 7 2 1 1 1 2 3 2 2
4 7 2 1 1 1 1 2 2 2
4 4 4 2 1 1 1 3 2 5 2
4 7 2 1 3 4 2 4 1 3
5 4 7 2 1 1 1 3 ND 2 1
4 7 2 1 1 1
6 3 7 2 1 1 1 2 ND 2 2
4 3 2 1 1 1 3 1 2 1
7 3 6 1 1 1 1 2 ND 2 2
4 7 1 2 1 1 3 ND 5 2
8 4 7 2 1 1 1 3 3 1 1
2 2 2 1 1 1 ND 4 1 4
9 4 7 2 1 1 1 1 ND 4 2
5 1 2 1 1 1 4 ND 2 2
10 ND 7 2 1 1 1 2 ND ND ND
ND 7 2 1 1 1 1 ND ND ND
NOTE.—ND  not determined.
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Figure 3 Results obtained with the Luria-Delbru¨ck formula, for
markers D9S752 and D9S61. On the basis of this formula, the ap-
proximation of the distance between the LCCS locus and markers
D9S61 and D9S752 is given as a function of the number of the
generations.
and D9S1831 was approximated to be 70 kb on ex-
tended DNA fibers (fig. 2c and d).
Analysis of Candidate Genes on 9q34
The FISH analysis of metaphase chromosomes (fig. 4)
with the PAC clone containing the NOTCH1 gene and
the cosmid for the ABL gene assigned theNOTCH1 gene
to a region telomeric to the ABL gene, positionally ex-
cluding it from the critical LCCS region and ruling it
out as a causative gene for LCCS. The FISH analysis of
the physical PAC clone containing the second candidate
gene, NGAL, demonstrated proximity of this gene to
marker D9S61, making the NGAL gene a positional can-
didate for LCCS. The PCR products of all seven exons
and of 150 bp of the promoter region, including the
TATA-signal region of NGAL, were analyzed by se-
quencing of the genomic DNA, and no variations be-
tween the two affected individuals and one control
sample were detected in the sequence analysis.
Discussion
We have reported here the assignment of the LCCS
locus to a restricted region on chromosome 9q34. The
chromosomal region was identified by use of only five
DNA samples from patients from two unrelated families
in the initial genome scan. This was justified because of
the assumption of a single causative mutation underlying
LCCS, suggested by the clustering of cases in the more
recently settled area of northeastern Finland. We ana-
lyzed a total of 650 polymorphic markers, but no single
chromosomal segment could be identified that was
shared by all five affected individuals. However, we were
able to identify four chromosomal regions that were IBD
in the siblings, but the alleles differed between the two
families; a conventional linkage study in the complete
DNAmaterial of 10 families revealed evidence of linkage
for chromosome 9q34 and excluded the other three
regions. It was surprising that the three siblings of one
family shared a total of only eight chromosomal seg-
ments. Our previous (Pekkarinen et al. 1998) and pre-
sent findings suggest that, in the locus search in recessive
diseases with complete penetrance, it initially is sufficient
to genotype only two or three affected siblings, to iden-
tify the chromosomal segments of interest, which then
can be further analyzed in the complete DNA material
of the family.
Shortcut strategies to assign disease loci have been
described elsewhere; they include use of samples from
three or four patients who are distant relatives (Nikali
et al. 1995), as well as the pooling of DNA samples
(Arbour et al. 1997). LCCS families could not be traced
back to common ancestors; but they were regionally
clustered, which suggests that such an ancestor exists.
We would not have been able, with a routinely adapted
density of DNA markers, to detect the linkage either by
pooling the DNA samples or by analyzing a single pa-
tient per family, because of the shortness of the chro-
mosomal region shared by the affected fetuses.
The observed obligatory recombinations in the LCCS
families restricted the locus to a 4-cM region. Analysis
of the ancient core haplotype restricted this critical chro-
mosomal region further, to an ∼0.5-cM region between
the markers D9S903 and D9S61, and the detected link-
age disequilibrium further restricted it to !100 kb in the
vicinity of D9S61. The short genetic interval revealing
linkage disequilibrium in LCCS alleles supports the sce-
nario of the early introduction of the LCCS mutation
into this population (de la Chapelle 1993; Peltonen et
al. 1995). However, the clustering of the disease gene
within the recently settled northeastern part of Finland,
as well as the clustering of grandparents’ birthplaces,
suggests the opposite—a late introduction of the gene
into the Finnish population (Vuopala and Herva 1994).
This discrepancy is peculiar and exceptional, compared
with what is observed in other Finnish diseases. In the
case of infantile-onset spinocerebellar ataxia, linkage
disequilibrium was detected over a 2-cM region, and the
genealogical search combined with the haplotype anal-
yses suggested that the mutation was introduced some
40 generations ago and that the mutation then spread
with the main migrationmovement fromwestern to east-
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Figure 4 a, Results of FISH analysis of metaphase chromosomes, with clones for the NOTCH1 gene (red) and the ABL gene (green) The
NOTCH1 clone assigns a more-telomeric region than does the ABL clone, localizing the NOTCH1 to the telomeric border of the LCCS region,
which is restricted by obligatory recombinations. b, Results of metaphase FISH analysis, which indicate the vicinity of the clones for the NGAL
gene (red) and for marker D9S61 (green).
ern Finland (Varilo et al. 1996a). Another Finnish dis-
ease, the variant form of infantile neuronal ceroid li-
pofuscinosis is still clustered within a small region of
southern Ostrobothnia, and linkage disequilibrium has
been detected over an 11-cM interval. This is in agree-
ment with the genealogical tracing of ancestors to the
same community, suggesting a relatively new mutation
introduced some 20-30 generations ago (Varilo et al.
1996b). In both cases, the genealogy and linkage-dise-
quilibrium results predict a similar age range for the
mutation.
The population history of northern Finland, together
with the clustering of LCCS cases, supports the idea of
the late introduction of this disease gene. The northern
and eastern parts of Finland were inhabited during the
16th and 17th centuries, after the east-to-west migration
(Solantie 1988). This movement spread the rare genes
to internal isolates, where the disease-gene frequencies
remained stable until the present century (Norio et al.
1973). We assume that the ancestors carrying the LCCS
mutation arrived in northeastern Finland during the late
17th century, when this region was settled by small im-
migrants groups from the western part of Finland. How-
ever, on the basis of linkage disequilibrium, the predicted
age of the ancestor mutation would be 1100 generations.
The possibility of several founders carrying the same
LCCS mutation and inhabiting this part of Finland at
the same time period cannot be excluded, nor can car-
riers who would have arrived from Russia and who
might have brought an old mutation into eastern
Finland.
The nature of the chromosomal region of LCCS also
may explain the discrepancy between the expected mu-
tational age and a short segment of linkage disequilib-
rium. The LCCS locus shares the chromosomal region
of 9q34 with the neoplasia-associated chromosomal
translocation locus (Carrol et al. 1987), a region with a
high frequency of recombination. Furthermore, the
LCCS locus is telomeric, a location prone to recombi-
nation. When the physical distances to the genetic in-
terval in this region are compared, the clones formarkers
D9S752 and D9S1831 are separated by 70 kb, on the
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basis of fiber FISH, whereas the genetic distance between
them is 11.2 cM, suggesting a high v value in this DNA
region. Therefore the shortness of the core haplotype
may reflect the high number of recombinations in this
region rather than the number of generations elapsed.
NOTCH 1 is a large transmembrane protein in which
a disease-associated mutation, t(7;9) translocation, ini-
tially was described in a T-cell leukemia (Ellisen et al.
1991). Studies of the oncogenic activity of the truncated
NOTCH 1 have demonstrated that NOTCH 1 plays a
role in the determination of cell fate during early fetal
development (Lardelli et al. 1995) NOTCH 1 protein is
suggested to be essential for signal transduction (Lieber
et al. 1993), and NOTCH 1D1 knockout mice show high
lethality (Conlon et al. 1995). All these findings have
made the NOTCH1 a good candidate gene for LCCS.
However, our FISH data clearly assigned the NOTCH1
to a region outside the critical chromosomal region,
thereby excluding it as a causative gene of LCCS.
The NGAL belongs to the lipocalin superfamily
(Bundgaard et al. 1994). It is believed to bind small
lipophilic molecules and to act as a modulator of in-
flammation. It is mitogenic and enhances cell growth
and proliferation. Neither the ligand nor the receptor
for this extracellular protein has been characterized
(Flower 1994). The gene is known to be expressed in
fetal spleen and lung, as well as in adult bone marrow
and tissues involved in the inflammatory response.
(Cowland and Borregaard 1997). The expression pattern
of the protein in the fetal CNS is not known. Our se-
quence analysis of the coding region of the NGAL gene
did not reveal differences in LCCS patients compared
with controls. However, neither nucleotide changes in
other parts of the gene nor the possibility of gene-dosage
effect of this interesting gene, known to be involved to
cell regulation, can be excluded.
LCCS is a motoneuron disease, as is spinal muscular
atrophy (SMA), a disease that occasionally presents with
artrogryposis and fetal akinesia sequence. SMA also is
known to be associated with anterior-horn-cell loss
(Burglen et al. 1996; Devriendt et al. 1996; Rudnik-
Schoneborn et al. 1996). In this disorder, however, the
descending tracts of the spinal cord are preserved. In an
earlier report, we excluded the SMA locus at 5q as being
the LCCS locus (Vuopala et al. 1995). LCCS resembles
more the adult motoneuron disease amyotrophic lateral
sclerosis, in which the motoneurons of the spinal cord
often are seen to be affected, whereas in LCCS the de-
generation of motoneurons already occurs during fetal
development (Herva et al. 1988; Vuopala et al. 1995).
Assignment of the LCCS locus provides a tool for iso-
lation of the gene underlying lethal motoneuron disease.
Identification of the gene defect is necessary for under-
standing the pathogenesis of LCCS and the normal de-
velopment of motoneurons. It will also offer an oppor-
tunity for development of a mouse model for moto-
neuron disease, facilitating detailed monitoring of the
disease process at the tissue level.
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